{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:46:25Z","timestamp":1781520385919,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jneuroim.2017.02.004","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T04:48:27Z","timestamp":1486442907000},"page":"82-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Is MuSK myasthenia gravis linked to IgG4-related disease?"],"prefix":"10.1016","volume":"305","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2139-3582","authenticated-orcid":false,"given":"Pooja","family":"Raibagkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2017.02.004_bb0005","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jneuroim.2017.02.004_bb0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1405.012","article-title":"Response to therapy in myasthenia gravis with anti-MuSK antibodies","volume":"1132","author":"Evoli","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2017.02.004_bb0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biocel.2010.10.008","article-title":"Muscle specific kinase: organiser of synaptic membrane domains","volume":"43","author":"Ghazanfari","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jneuroim.2017.02.004_bb0020","doi-asserted-by":"crossref","first-page":"401890","DOI":"10.1155\/2012\/401890","article-title":"IgG4-related perineural disease","volume":"2012","author":"Inoue","year":"2012","journal-title":"Int. J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2017.02.004_bb0025","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2017.02.004_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease","author":"Mattoo","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2017.02.004_bb0035","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2017.02.004_bb0040","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1507\/endocrj.K09E-277","article-title":"Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity","volume":"56","author":"Shimatsu","year":"2009","journal-title":"Endocr. J."},{"key":"10.1016\/j.jneuroim.2017.02.004_bb0045","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2017.02.004_bb0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e31829cce35","article-title":"IgG4-related disease and hypertrophic pachymeningitis","volume":"92","author":"Wallace","year":"2013","journal-title":"Medicine (Baltimore)"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816304684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816304684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:29:12Z","timestamp":1759048152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816304684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":10,"alternative-id":["S0165572816304684"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.02.004","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is MuSK myasthenia gravis linked to IgG4-related disease?","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}